Formulation of ketotifen fumarate fast-melt granulation sublingual tablet

AAPS PharmSciTech

Volumn 11, Issue 2, 2010, Pages 679-685

  Tayel, Saadia A ^a   Soliman, Iman I ^a   Louis, Dina ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Chicken pouches; Fast melt granulation; Ketotifen fumarate; Permeation; Sublingual tablet; Zaditen

Indexed keywords

KETOTIFEN FUMARATE; MACROGOL 4000; MACROGOL 6000; MANNITOL; SUCROSE; ANTIASTHMATIC AGENT; DRUG CARRIER; EXCIPIENT; KETOTIFEN; MACROGOL DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CHICKEN; DRUG BIOAVAILABILITY; DRUG GRANULATION; DRUG MIXTURE; DRUG PENETRATION; EX VIVO STUDY; FIRST PASS EFFECT; NONHUMAN; PRIORITY JOURNAL; RABBIT; TABLET DISINTEGRATION; TABLET FORMULATION; ANIMAL; CHEMISTRY; DRUG FORMULATION; HEAT; MALE; PROCEDURES; SUBLINGUAL DRUG ADMINISTRATION;

ADMINISTRATION, SUBLINGUAL; ANIMALS; ANTI-ASTHMATIC AGENTS; DRUG CARRIERS; DRUG COMPOUNDING; EXCIPIENTS; HOT TEMPERATURE; KETOTIFEN; MALE; POLYETHYLENE GLYCOLS; RABBITS;

EID: 77954788579     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9425-9     Document Type: Article

References (49)

1. Schaefer T, Holm P, Kristensen HG. Melt granulation in a laboratory scale high shear mixer. Drug Dev Ind Pharm. 1990;16(8):1249-77. (Pubitemid 20170821)
2. Thies R, Kleinebudde P. Melt pelletization of a hygroscopic drug in a high shear mixer. Part I: Influence of process variables. Int J Pharm. 1999;188:131-43.
3. Voinovich D, Moneghini M, Perisutti B, Filipovic-Gricic J, Gabnar I. Preparation in a high shear mixer of sustained release pellets by melt pelletization. Int J Pharm. 2000;203:235-44.
4. Ochoa L, Igartua M, Hernandez RM, Gascon AR, Pedraz JL. Preparation of sustained release hydrophilic matrices by melt granulation in a high shear mixer. J Pharm Pharm Sci. 2005;8(2):132-40.
5. Rodriguez L, Cavallari C, Passerini N, Albertini B, Gonzalez ML. Fini. Preparation and characterization by morphological analysis of diclofenac/PEG 4000 granules obtained using three different techniques. Int J Pharm. 2002;242(1-2):285-9.
6. Damian F, Balton N, Naisens L, Balzarini J, Kinget R, Augustijns P et al. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and gelucire 44/14. Eur J Pharm Sci. 2000;10:311-22.
7. Passerini N, Albertini B, Gonzalez-Rodriguez ML, Cavallarri C, Rodriguez L. Preparation and characterization of ibuprofenpoloxamer 199 granules obtained by melt granulation. Eur J Pharm Sci. 2002;15:71-8.
8. Abu Izza, Khawla A, Li Vincent H, Look LL, Parr GD, Schineller MK. Fast dissolving tablet. US patent 673 3781;2004.
9. Perissutti B, Rubessa F, Moneghini M, Vocnviich D. Formulation design of carbamazepine fast release tablets prepared by melt granulation technique. Int J Pharm. 2003;329:72-80.
10. Yang D, Kulkami R, Behme RJ, Kotiyan PN. Effect of the melt granulation technique on the dissolution characteristics of griseofulvin. Int J Pharm. 2007;329:72-80.
11. Gelucires: Pharmaceutical Applications. http://www.Pharmainfo.net/ reviews/gelucires-pharmaceutical-applications.
12. Grant SM, Goa KL, Fitton A, Sorkin EM. Ketotifen, a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in asthma and allergic disorders. Drugs. 1990;40:412-48.
13. Grahnen A, Lonnebo A, Beck O, Eckernas SA, Dahlstrom B, Lindstrom B. Pharmacokinetis of ketotifen after oral administration to healthy male subjects. Biopharm Drug Dispos. 1992;13(4):255-62.
14. Gosh TK, Pfister WR. Drug delivery to the oral cavity: molecules to market. Taylor & Francis Gp. (Pub.), USA; 2005.
15. El Samaligy MS, Yehia SA, Basilios EB. Formulation and evaluation of diclofenac sodium buccoabhesive disc. Int J Pharm. 2004;286:27-39.
16. Dollery C. Therapeutic drugs. 2nd ed. U. K: Churchill Livingstone; 1999. p. K25-8.
17. Rowe RC, Sheskey PJ, Owe SC. Handbook of pharmaceutical excipients. 5th ed. Great Britain: Pharmaceutical; 2006. p. 459-263. 466-70.
18. The British Pharmacopoeia. The Stationary Office, UK; 2007, pp. A207, 304, 208, 397, 405.
19. The USP NF. Asian Edn., US pharmacopoeial Convention, NC, Canada, Toronto; 2005, pp. 2677-2700.
20. Lachman L, Leiberman HA, Kanig JK. The theory & practice of industrial pharmacy. Philadelphia, PA: Lee & Frebiger; 1986. p. 36-102. 184, 293, 297.
21. European Pharmacopoeia. 4th Edn, Council of Europe, Strasbourg, France. 2002, pp. 1433-5.
22. Florey K. Analytical profiles of drug substances, vol. 13. USA: Academic; 1984. p. 239-63.
23. Sloan KB, Bcall HD, Weimar WR, Villanueva R. Effect of receptor phase composition on the permeability of hairless mouse skin in diffusion cell experiments. Int J Pharm. 1991;73:97-104.
24. Bird AP, Faltinek JR, Shojaei AH. Transbuccal peptide delivery: stability and in vitro permeation studies on endomorphin-1. J Control Release. 2001;73:31-6.
25. 9-tetrahydrocannabinol in rabbits. Eur J Pharm Sci. 2005;26:71-7.
26. Mannila J, Järvinen K, Tarvainen M, Jarho P. Sublingual administration of Δ9-tetrahydrocannabinol in rabbits. Life Sci. 2006;78:1911-4.
27. Chiang CH, Lui YL, Chen JR. Therapeutic effect and pharmacokinetics of ketotifen transdermal delivery systems. Drug Dev Ind Pharm. 1998;24(3):213-7.
28. Ndindayino F, Vervaet C, Van Den Mooter G, Remon JP. Bioavailability of hydrochlorothiazide from isomat based moulded tablets. Int J Pharm. 2002;246:199-202.
29. Scwarbrick J., Boylan JC. Encyclopedia of Pharmaceutical Technology. 1991.
30. Shojaei A. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharmaceut Sci. 1998;1:15-30.
31. Gohel MC, Jogani PD. A review of coprocessed directly compressibile excipients. J Pharm Pharmaceut Sci. 2005;8(1):76-93.
32. Bolhius GR, Lerk CF. Comparative evaluation of excipients for direct compression. Part I. Pharm Wkly. 1973;108:469-81.
33. Buckton G, Yonemochi E, Yoon WL, Moffat AC. Water sorption and near IR spectroscopy to study the differences between microcrystalline cellulose and silicified microcrystalline cellulose before and after wet granulation. Int J Pharm. 1999;181:41-7.
34. Gordon MS. Process considerations in reducing tablet friability and their effect on in-vitro dissolution. Drug Devel Ind Pharm. 1994;20(1):11-29.
35. Mitrevej A, Sinchaipanid N, Faroongsarng D. Spray dried rice starch: comparative evaluation of direct compression of tablets. Drug Devel Ind Pharm. 1986;12:2091-111.
36. Mesmukl A, Phaechamud T. Indomethacin-polyethylene glycoltablet fabricated with mold technique. J Metals, Materials and Minerals. 2008;18(2):157-67.
37. Leonardi D, Barrera MG, Lamac MC, Salomn CJ. Development of prednisolone PEG 6000 fast release tablets from solid dispersions: solid state characterization, dissolution behavior and formulation parameters. AAPS Pharm Sci Tech. 2007;8(4): Article 108.
38. Verhoeven E, De Beer T R M, Schacht E, Vanden Mooter G, Remon JP, Vervaet C. Influence of PEG/polyethylene oxide on the release characterisitics of sustained release ethylcellulose mini-matrices produced by hot melt extrusion: in vitro and in vivo evaluations. Eur J Pharm Biopharm. 2009;72:463-70.
39. Herkenne C, Naik A, Kalia YN, Hadgraft I, Guy RH. Effect of propylene glycol on ibuprofen absorption into human skin in vivo. J Pharm Sci. 2008;97(1):185-97.
40. Cho YA, Gwak HS. Transdermal delivery of ketorolac tomethamine: effects of vehicles and penetration enhancers. Drug Devel Ind Pharm. 2004;30(6):557-64.
41. Gwak HS, Oh IS, Chum IK. transdermal delivery of ondansetrone hydrochloride: effects of vehicles and penetration enhancers. Drug Devel Ind Pharm. 2004;30(2):187-94.
42. Veuillez FA, Deshusses J, Buri P. Synthesis and characterization of an accylated dipeptide (Myr-Try-Leu) with modified transbuccal properties. Eur J Pharm Biopharm. 1999;48(1):21-6.
43. Rathbone MJ, Hadgraft J. Absorption of drugs from human oral cavity. Int J Pharm. 1991;74:9-24.
44. Haegeli L, Brunner La Rocca HP, Wenk M, Pfisterer M, Drewe J, Kruhenbuhl S. Sublingual administration of furosemide: a new application of an old drug. Br J Clin Pharmacol. 2007;64(6):804-9.
45. Altay B, Horasanli K, Sarica K, Tanrivereti O, Kendirci M, Miroglu C. Double blind placebo-controlled, randomizied clinical trial of sublingual or intramuscular piroxicam in the treatment of renal colic: a comparative study. Urol Int. 2007;79:73-5.
46. Feitosa FE, de Amorin MM, Alencar Jr CA, Coutinho IC, Sampaio ZS. New formulation of sublingual misoprostol (25 mcg) for induction of labor. Rev Assoc Med Bras. 2006;52:251-5.
47. Hoj L, Cardoso P, Nielsen BB, Hridman L, Nielsen J, Aaby P. The effect of sublingual misoprostol in a primary health centre in Guinia-Bissau: randomizied double blind clinical trial. BMJ. 2005;1(331):723.
48. Molander L, Lunell E. Pharmacokinetic investigation of a nicotine sublingual tablet. Eur J Clin Pharmacol. 2001;56(11):813-49.
49. Adams D. Penetration of water through human and rabbit oral mucosa in vitro. Arch Oral Biol. 1974;19:865-72.